Bridgeway Capital Management’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-13,100
Closed -$46.9K 1357
2023
Q3
$46.9K Hold
13,100
﹤0.01% 1310
2023
Q2
$48.3K Sell
13,100
-1,580,000
-99% -$5.86M ﹤0.01% 1333
2023
Q1
$5.27M Sell
1,593,100
-1,046,000
-40% -$3.62M 0.14% 239
2022
Q4
$10.2M Buy
2,639,100
+188,800
+8% +$582K 0.27% 77
2022
Q3
$5.95M Buy
2,450,300
+2,187,200
+831% +$5.25M 0.16% 210
2022
Q2
$521K Hold
263,100
0.01% 867
2022
Q1
$481K Buy
263,100
+250,000
+1,908% +$390K 0.01% 947
2021
Q4
$18K Sell
13,100
-250,000
-95% -$329K ﹤0.01% 1255
2021
Q3
$297K Sell
263,100
-100,000
-28% -$140K 0.01% 1160
2021
Q2
$581K Sell
363,100
-180,000
-33% -$317K 0.01% 1023
2021
Q1
$956K Buy
+543,100
New +$1.24M 0.02% 879

Other funds holding ADMA